Innovation and Technology Commission

Organisation

Awards made

  • City University of Hong Kong

    ITSP, Machine Learning-based Mobile Element Testing for Personalized Cancer Screening, ITS/101/22, HK$1.4m, 2024, 1 Jan 2024

  • City University of Hong Kong

    PRP, Development of a Novel Permeable Transcriptional Factor System for Generating Personalized Neural Stem Cells in Regenerative Medicine, PRP/021/24FX, HK$696k, 2024, 1 Jan 2024

  • Chinese University of Hong Kong

    MHKJFS, Screening Molecular Markers of Knee Osteoarthritis and Developing Regenerative Medicine Using Joint-on-a-chip Systems, MHP/101/23, HK$1.3m, 2024, 1 Jan 2024

  • Hong Kong University of Science and Technology

    TCFS, The Studies of Astrocyte Reprogramming to Dopaminergic Neurons by the Natural Product of Lipoic Acid Derivative PT109 and Its Composition in treating Parkinson’s Disease and Its Mechanism, GHP/016/21SZ, HK$886k, 2023, 1 Jan 2023

  • Applied Science and Technology Research Institute

    ITSP, Detecting Early Signs of Dementia through Speech Analysis, ARD/293, HK$2.8m, 2023, 1 Jan 2023

  • Hong Kong University of Science and Technology

    PRP, Early Detection of Breast Cancer through Wearable Devices and Machine Learning, PRP/068/21FX, HK$979k, 2022, 1 Jan 2022

  • Applied Science and Technology Research Institute

    ITSP, Intelligent Assessment for Elderly Fall Risk, ARD/287, HK$2.8m, 2022, 1 Jan 2022

  • Chinese University of Hong Kong

    TCFS, Engineering Exosomes for Tissue Regeneration and Osteoarthritis Treatment, GHP/074/20SZ, HK$1.4m, 2022, 1 Jan 2022

  • Chinese University of Hong Kong

    PRP, Artificial intelligence assisted osteoporosis detection system, PRP/098/20FX, HK$1.5m, 2021, 1 Jan 2021

  • The University of Hong Kong

    PRP, Establishing the First Southern Chinese Haplobank of Clinical-Grade Human Induced Pluripotent Stem Cell Lines for Regenerative Medicine, PRP/088/20FX, HK$2.8m, 2021, 1 Jan 2021

  • The University of Hong Kong

    PRP, Pharmacological effects of cultivated Amauroderma rugosum of Hong Kong origin on aging-related diseases and identification of its active ingredients, PRP/100/20FX, HK$1.1m, 2021, 1 Jan 2021

  • Hong Kong University of Science and Technology

    MHKJFS, Regeneration and Repair of Penile Cavernosa Based on Muscle Stem Cells Differentiation and 3D Printing Technology, MHP/003/19, HK$450k, 2021, 1 Jan 2021

  • The University of Hong Kong

    PRP, Cardiovascular risk prediction model for patients on lipid modifying drugs, PRP/070/19FX, 2020, 1 Jan 2020

  • Chinese University of Hong Kong

    UICP, To Develop a Hybrid Intervention-assessment System for Elderly Home Use ¡V Vibration and Sensor-based Balancing Ability Monitoring Device, UIM/388, HK$1.3m, 2019, 1 Jan 2019

  • Chinese University of Hong Kong

    ITSP, An Artificial Intelligence-Enabled Tool For Automated Recognition Of Vertebral Fracture And Intervertebral Disc Space Narrowing In Elderly Chinese Population, ITS/334/18, HK$940k, 2019, 1 Jan 2019

  • Chinese University of Hong Kong

    MRP, Simultaneous Dual-Task Cycling Exercise Training on Cognitive Function for the Elderly, MRP/010/18, HK$2.7m, 2019, 1 Jan 2019

  • Hong Kong Baptist University

    TCFS, Effects Of A Novel Smurf1 Inhibitor Loaded In Alginate Hydrogel On Local Bone Formation In Distinctive Age-related Osteoporosis During Spinal Fusion, GHX/013/18SZ, HK$920k, 2019, 1 Jan 2019

Sources: openalex.org

Funded papers

Sources: api.crossref.org